$8.61 Billion is the total value of Bellevue Group AG's 220 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STNE | Exit | STONECO LTD | $0 | – | -4,300 | -100.0% | -0.00% | – |
| CLX | Exit | CLOROX CO DEL | $0 | – | -1,200 | -100.0% | -0.00% | – |
| OLED | Exit | UNIVERSAL DISPLAY CORP | $0 | – | -1,365 | -100.0% | -0.00% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -1,000 | -100.0% | -0.00% | – |
| JD | Exit | JD.COM INCspon adr cl a | $0 | – | -3,600 | -100.0% | -0.00% | – |
| AZPN | Exit | ASPEN TECHNOLOGY INC | $0 | – | -1,874 | -100.0% | -0.00% | – |
| SPOT | Exit | SPOTIFY TECHNOLOGY SA | $0 | – | -1,100 | -100.0% | -0.00% | – |
| FTNT | Exit | FORTINET INC | $0 | – | -803 | -100.0% | -0.00% | – |
| EA | Exit | ELECTRONIC ARTS INC | $0 | – | -2,270 | -100.0% | -0.00% | – |
| AXP | Exit | AMERICAN EXPRESS CO | $0 | – | -1,500 | -100.0% | -0.00% | – |
| GGG | Exit | GRACO INC | $0 | – | -4,500 | -100.0% | -0.00% | – |
| MKL | Exit | MARKEL CORP | $0 | – | -300 | -100.0% | -0.00% | – |
| ENTG | Exit | ENTEGRIS INC | $0 | – | -3,000 | -100.0% | -0.00% | – |
| CYBR | Exit | CYBERARK SOFTWARE LTD | $0 | – | -2,100 | -100.0% | -0.00% | – |
| NYT | Exit | NEW YORK TIMES COcl a | $0 | – | -7,500 | -100.0% | -0.00% | – |
| LYV | Exit | LIVE NATION ENTERTAINMENT IN | $0 | – | -4,700 | -100.0% | -0.01% | – |
| CLLS | Exit | CELLECTIS S Aspon ads | $0 | – | -82,500 | -100.0% | -0.01% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -10,400 | -100.0% | -0.02% | – |
| ZTS | Exit | ZOETIS INCcl a | $0 | – | -7,100 | -100.0% | -0.02% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -7,552 | -100.0% | -0.02% | – |
| SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -21,500 | -100.0% | -0.02% | – |
| DGX | Exit | QUEST DIAGNOSTICS INC | $0 | – | -15,250 | -100.0% | -0.03% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -23,100 | -100.0% | -0.03% | – |
| OSCR | Exit | OSCAR HEALTH INCcl a | $0 | – | -679,952 | -100.0% | -0.06% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -23,000 | -100.0% | -0.06% | – |
| IMAB | Exit | I MABsponsored ads | $0 | – | -144,957 | -100.0% | -0.07% | – |
| ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -126,600 | -100.0% | -0.08% | – |
| NEO | Exit | NEOGENOMICS INC | $0 | – | -469,695 | -100.0% | -0.16% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -131,376 | -100.0% | -0.40% | – |
| VCRA | Exit | VOCERA COMMUNICATONS INC | $0 | – | -1,160,613 | -100.0% | -0.78% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
- Bellevue Asset Management (UK) Ltd. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.